Overall, our study indicates that m6A‐modified LNCAROD confers radioresistance of esophageal squamous cell carcinoma through stabilising PARP1, thus providing a new perspective and clue to alleviate radioresistance. This evidence concerns the gene PARP1 and esophageal squamous cell carcinoma.